A prospective cohort study showed that compared with non-HF subjects (3.5 μM), the median plasma TMAO in HF patients increased to 5.0 μM, which was significantly correlated with the HF biomarker BNP (Tang et al., 2014). This evidence concerns the gene NPPB and hydrops fetalis.